Nutex Health Inc. (NUTX)
NASDAQ: NUTX · Real-Time Price · USD
127.83
0.00 (0.00%)
Oct 29, 2025, 4:00 PM EDT - Market open
Nutex Health Revenue
Nutex Health had revenue of $211.79M in the quarter ending March 31, 2025, with 213.98% growth. This brings the company's revenue in the last twelve months to $624.28M, up 141.25% year-over-year. In the year 2024, Nutex Health had annual revenue of $479.95M with 93.80% growth.
Revenue (ttm)
$624.28M
Revenue Growth
+141.25%
P/S Ratio
1.08
Revenue / Employee
$780,356
Employees
800
Market Cap
710.11M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 479.95M | 232.30M | 93.80% |
| Dec 31, 2023 | 247.65M | 28.35M | 12.93% |
| Dec 31, 2022 | 219.29M | -112.24M | -33.85% |
| Dec 31, 2021 | 331.53M | 57.50M | 20.98% |
| Dec 31, 2020 | 274.03M | 176.97M | 182.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
NUTX News
- 10 days ago - NUTEX HEALTH PROVIDES CORPORATE UPDATE - PRNewsWire
- 13 days ago - Nutex Health (NUTX) Securities Suit Alleges Fraud and Financial Misstatements-- Hagens Berman - PRNewsWire
- 15 days ago - NUTEX DEADLINE REMINDER: Bragar Eagel & Squire, P.C. Urges Nutex Health Investors to Contact the Firm Before the October 21st Deadline - GlobeNewsWire
- 17 days ago - NUTX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health - GlobeNewsWire
- 19 days ago - SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health - PRNewsWire
- 23 days ago - NUTEX DEADLINE REMINDER: Bragar Eagel & Squire, P.C. Urges Nutex Investors to Contact the Firm Before the October 21st Deadline - GlobeNewsWire
- 24 days ago - Nutex Health and its Hospitals Earn Record-Breaking 20 Awards and Accolades in Q3 - PRNewsWire
- 4 weeks ago - Nutex Health (NUTX) Securities Suit Alleges Fraud and Financial Misstatements – Hagens Berman - GlobeNewsWire